|

BNT326 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1/2: 2

Top Sponsors

  • BioNTech SE2

Indications

  • Lung Cancer2
  • Cancer2
  • Advanced Solid Tumor1
  • Non Small Cell Lung Cancer1

San Francisco, California1 trial

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

University of California San Francisco

Phase 1/2

Fairfax, Virginia1 trial

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

NEXT Virginia

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.